Locoregional therapies, such as TACE with 5-fluorouracil (5-FU), can induce MDSC accumulation in HCC, particularly polymorphonuclear MDSCs (PMN-MDSCs), thereby weakening the antitumor effects of CD8+ T cells and NK cells[68]. Here, CD8A is linked to hepatocellular carcinoma.